You can buy or sell ContraFect and other stocks, options, ETFs, and crypto commission-free!
ContraFect Corporation Common Stock, also called ContraFect, is a clinical stage biotechnology company , which engages in discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases. Its pipeline consists of CF-301, a bacteriophage-derived lysin with potent activity against Staphylococcus aureus bloodstream infections; and CF-404, which composed of three fully human monoclonal antibodies designed to treat all seasonal strains of human influenza. Read More The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.
Yonkers, New York
52 Week High
52 Week Low
-$0.11 per share